{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T13:37:02Z","timestamp":1792157822353,"version":"4.4.0"},"reference-count":75,"publisher":"SAGE Publications","issue":"2","license":[{"start":{"date-parts":[[2018,11,15]],"date-time":"2018-11-15T00:00:00Z","timestamp":1542240000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Obstet Med"],"published-print":{"date-parts":[[2019,6]]},"abstract":"<jats:p> Fetal tachycardia is a rare complication during pregnancy. After exclusion of maternal and fetal conditions that can result in a secondary fetal tachycardia, supraventricular tachycardia is the most common cause of a primary sustained fetal tachyarrhythmia. In cases of sustained fetal supraventricular tachycardia, maternal administration of digoxin, flecainide, sotalol, and more rarely amiodarone, is considered. As these medications have the potential to cause significant adverse effects, we sought to examine maternal safety during transplacental treatment of fetal supraventricular tachycardia. In this narrative review we summarize the literature addressing pharmacologic properties, monitoring, and adverse reactions associated with medications most commonly prescribed for transplacental therapy of fetal supraventricular tachycardia. We also describe maternal monitoring practices and adverse events currently reported in the literature. In light of our findings, we provide clinicians with a suggested maternal monitoring protocol aimed at optimizing safety. <\/jats:p>","DOI":"10.1177\/1753495x18808118","type":"journal-article","created":{"date-parts":[[2018,11,16]],"date-time":"2018-11-16T02:52:03Z","timestamp":1542336723000},"page":"66-75","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":26,"title":["Maternal monitoring and safety considerations during antiarrhythmic treatment for fetal supraventricular tachycardia"],"prefix":"10.1177","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9140-8735","authenticated-orcid":false,"given":"Isabelle","family":"Malham\u00e9","sequence":"first","affiliation":[{"name":"Department of Medicine, Women and Infants Hospital, Providence, RI, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christy","family":"Gandhi","sequence":"additional","affiliation":[{"name":"Department of Medicine, Women and Infants Hospital, Providence, RI, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gofran","family":"Tarabulsi","sequence":"additional","affiliation":[{"name":"Department of Medicine, Women and Infants Hospital, Providence, RI, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew","family":"Esposito","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Women and Infants Hospital, Providence, RI, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristin","family":"Lombardi","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Hasbro Children\u2019s Hospital, Providence, RI, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antony","family":"Chu","sequence":"additional","affiliation":[{"name":"Department of Medicine, Rhode Island Hospital, Providence, RI, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenneth K","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Medicine, Women and Infants Hospital, Providence, RI, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","published-online":{"date-parts":[[2018,11,15]]},"reference":[{"key":"bibr1-1753495X18808118","doi-asserted-by":"publisher","DOI":"10.1136\/adc.55.7.506"},{"key":"bibr2-1753495X18808118","doi-asserted-by":"publisher","DOI":"10.2165\/00128072-200204010-00006"},{"key":"bibr3-1753495X18808118","first-page":"2487","volume":"59","author":"Sweha A","year":"1999","journal-title":"Am Fam Phys"},{"key":"bibr4-1753495X18808118","doi-asserted-by":"publisher","DOI":"10.1080\/14767058.2017.1350159"},{"key":"bibr5-1753495X18808118","doi-asserted-by":"publisher","DOI":"10.1161\/01.cir.0000437597.44550.5d"},{"key":"bibr6-1753495X18808118","doi-asserted-by":"publisher","DOI":"10.1053\/sper.2000.1654"},{"key":"bibr7-1753495X18808118","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.111.026120"},{"key":"bibr8-1753495X18808118","doi-asserted-by":"publisher","DOI":"10.1007\/s00246-003-0589-x"},{"key":"bibr9-1753495X18808118","doi-asserted-by":"publisher","DOI":"10.1136\/hrt.2005.069369"},{"key":"bibr10-1753495X18808118","doi-asserted-by":"publisher","DOI":"10.1016\/0735-1097(96)00054-X"},{"key":"bibr11-1753495X18808118","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1016\/S1701-2163(15)30816-1","volume":"35","author":"Desilets V","year":"2013","journal-title":"J Obstetr Gynaecol Canada: JOGC\u2009=\u2009Journal D'obstetrique et Gynecologie du Canada"},{"key":"bibr12-1753495X18808118","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajog.2014.12.018"},{"key":"bibr13-1753495X18808118","doi-asserted-by":"publisher","DOI":"10.1136\/bcr-2012-008515"},{"key":"bibr14-1753495X18808118","doi-asserted-by":"publisher","DOI":"10.1007\/s002460010279"},{"key":"bibr15-1753495X18808118","doi-asserted-by":"publisher","DOI":"10.3109\/14767058.2011.554924"},{"key":"bibr16-1753495X18808118","doi-asserted-by":"publisher","DOI":"10.1111\/j.1651-2227.1998.tb01508.x"},{"key":"bibr17-1753495X18808118","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjcard.2012.01.388"},{"key":"bibr18-1753495X18808118","doi-asserted-by":"publisher","DOI":"10.1016\/j.hrthm.2016.03.023"},{"key":"bibr19-1753495X18808118","first-page":"1","volume":"7058","author":"Ekiz A","year":"2017","journal-title":"J Maternal Fetal Neonatal Med"},{"key":"bibr20-1753495X18808118","doi-asserted-by":"publisher","DOI":"10.1159\/000089052"},{"key":"bibr21-1753495X18808118","doi-asserted-by":"publisher","DOI":"10.1016\/S1297-9589(00)00003-5"},{"key":"bibr22-1753495X18808118","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9378(87)80309-5"},{"key":"bibr23-1753495X18808118","doi-asserted-by":"publisher","DOI":"10.2165\/00003088-198712040-00002"},{"key":"bibr24-1753495X18808118","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccc.2012.07.005"},{"key":"bibr25-1753495X18808118","unstructured":"Lanoxin (digoxin) tablets: manufacturer\u2019s prescribing information, pp. 3\u201318, https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2010\/020405s004lbl.pdf (2009, accessed 28 August 2018)."},{"key":"bibr26-1753495X18808118","doi-asserted-by":"publisher","DOI":"10.1007\/BF03259295"},{"key":"bibr27-1753495X18808118","doi-asserted-by":"publisher","DOI":"10.1055\/s-0036-1586241"},{"key":"bibr28-1753495X18808118","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9149(86)90855-6"},{"key":"bibr29-1753495X18808118","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.15.4.603"},{"key":"bibr30-1753495X18808118","unstructured":"DIGOXIN \u2013 Sun Pharmaceutical Industries, Inc. 2009, https:\/\/dailymed.nlm.nih.gov\/dailymed\/drugInfo.cfm?setid=62795623-a2bc-4dd2-8989-3b9782bfd80e (accessed 28 August 2018)."},{"key":"bibr31-1753495X18808118","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.56.2.260"},{"key":"bibr32-1753495X18808118","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjmed.2011.09.019"},{"key":"bibr33-1753495X18808118","doi-asserted-by":"publisher","DOI":"10.1016\/S0735-1097(97)00133-2"},{"key":"bibr34-1753495X18808118","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199307013290101"},{"key":"bibr35-1753495X18808118","doi-asserted-by":"publisher","DOI":"10.1016\/0735-1097(93)90403-N"},{"key":"bibr36-1753495X18808118","doi-asserted-by":"publisher","DOI":"10.4330\/wjc.v7.i2.76"},{"key":"bibr37-1753495X18808118","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198607033150106"},{"key":"bibr38-1753495X18808118","doi-asserted-by":"publisher","DOI":"10.1016\/j.hrthm.2014.07.031"},{"key":"bibr39-1753495X18808118","first-page":"209","volume":"32","author":"Razavi M.","year":"2005","journal-title":"Texas Heart Inst J"},{"key":"bibr40-1753495X18808118","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9149(84)90511-3"},{"key":"bibr41-1753495X18808118","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9149(92)91071-B"},{"key":"bibr42-1753495X18808118","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9149(97)89121-7"},{"key":"bibr43-1753495X18808118","doi-asserted-by":"publisher","DOI":"10.7812\/TPP\/12-086"},{"key":"bibr44-1753495X18808118","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9149(84)90509-5"},{"key":"bibr45-1753495X18808118","doi-asserted-by":"publisher","DOI":"10.1007\/s12012-016-9380-0"},{"key":"bibr46-1753495X18808118","doi-asserted-by":"publisher","DOI":"10.1111\/j.1742-6723.2006.00909.x"},{"key":"bibr47-1753495X18808118","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198908103210629"},{"key":"bibr48-1753495X18808118","first-page":"64e1","volume":"2014","author":"January CT","year":"2014","journal-title":"J Am Coll Cardiol"},{"key":"bibr49-1753495X18808118","doi-asserted-by":"publisher","DOI":"10.1517\/14656566.2013.759212"},{"key":"bibr50-1753495X18808118","unstructured":"Flecainide (Tambocor) Considerations for use, https:\/\/www.acc.org\/\u223c\/media\/Non-Clinical\/Files-PDFs-Excel-MS-Word-etc\/Tools and Practice Support\/Quality and Clinical Toolkits\/AFib Toolkit\/Flecainide.pdf?la=en (accessed 28 August 2018)."},{"key":"bibr51-1753495X18808118","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-139-12-200312160-00012"},{"key":"bibr52-1753495X18808118","first-page":"507","volume":"52","author":"Wehling M.","year":"2002","journal-title":"Arzneimittel-Forschung\/Drug Res"},{"key":"bibr53-1753495X18808118","doi-asserted-by":"publisher","DOI":"10.1093\/europace\/eup119"},{"key":"bibr54-1753495X18808118","doi-asserted-by":"publisher","DOI":"10.1093\/europace\/euq382"},{"key":"bibr55-1753495X18808118","doi-asserted-by":"publisher","DOI":"10.1007\/BF00609896"},{"key":"bibr56-1753495X18808118","doi-asserted-by":"publisher","DOI":"10.1016\/S0735-1097(03)00779-4"},{"key":"bibr57-1753495X18808118","unstructured":"Sotalol (Betapace, Sorine) Considerations for use. American College of Cardiology, https:\/\/www.acc.org\/tools-and-practice-support\/clinical-toolkits\/atrial-fibrillation-afib\/rate-rhythm-dosing-table\/sotalol (accessed 28 August 2018)."},{"key":"bibr58-1753495X18808118","doi-asserted-by":"publisher","DOI":"10.1111\/bcp.12763"},{"key":"bibr59-1753495X18808118","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.0000109494.05317.58"},{"key":"bibr60-1753495X18808118","doi-asserted-by":"publisher","DOI":"10.1016\/0028-2243(92)90174-W"},{"key":"bibr61-1753495X18808118","doi-asserted-by":"publisher","DOI":"10.1038\/nrcardio.2015.172"},{"key":"bibr62-1753495X18808118","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9149(93)90962-C"},{"key":"bibr63-1753495X18808118","doi-asserted-by":"publisher","DOI":"10.1016\/0002-8703(83)90006-6"},{"key":"bibr64-1753495X18808118","doi-asserted-by":"publisher","DOI":"10.1016\/0002-8703(91)90969-O"},{"key":"bibr65-1753495X18808118","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.160.12.1741"},{"key":"bibr66-1753495X18808118","first-page":"2189","volume":"68","author":"Siddoway LA.","year":"2003","journal-title":"Am Fam Phys"},{"key":"bibr67-1753495X18808118","doi-asserted-by":"publisher","DOI":"10.2165\/11532320-000000000-00000"},{"key":"bibr68-1753495X18808118","doi-asserted-by":"publisher","DOI":"10.1159\/000325464"},{"key":"bibr69-1753495X18808118","doi-asserted-by":"publisher","DOI":"10.1159\/000021030"},{"key":"bibr70-1753495X18808118","doi-asserted-by":"publisher","DOI":"10.4103\/0019-5359.56117"},{"key":"bibr71-1753495X18808118","doi-asserted-by":"publisher","DOI":"10.1002\/uog.64"},{"key":"bibr72-1753495X18808118","doi-asserted-by":"publisher","DOI":"10.1080\/17512433.2017.1344096"},{"key":"bibr73-1753495X18808118","doi-asserted-by":"publisher","DOI":"10.1002\/pd.542"},{"key":"bibr74-1753495X18808118","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.101.23.2721"},{"key":"bibr75-1753495X18808118","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1111\/j.1742-1241.2001.tb11125.x","volume":"55","author":"Abraham P.","year":"2001","journal-title":"Int J Clin Pract"}],"container-title":["Obstetric Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/1753495X18808118","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/1753495X18808118","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/1753495X18808118","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,27]],"date-time":"2025-02-27T18:07:56Z","timestamp":1740679676000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/1753495X18808118"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,11,15]]},"references-count":75,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2019,6]]}},"alternative-id":["10.1177\/1753495X18808118"],"URL":"https:\/\/doi.org\/10.1177\/1753495x18808118","relation":{},"ISSN":["1753-495X","1753-4968"],"issn-type":[{"value":"1753-495X","type":"print"},{"value":"1753-4968","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,11,15]]}}}